GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (FRA:NTP) » Definitions » Net Margin %

Abliva AB (FRA:NTP) Net Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Abliva AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Abliva AB's Net Income for the three months ended in Sep. 2024 was €-1.72 Mil. Abliva AB's Revenue for the three months ended in Sep. 2024 was €0.00 Mil. Therefore, Abliva AB's net margin for the quarter that ended in Sep. 2024 was 0.00%.

The historical rank and industry rank for Abliva AB's Net Margin % or its related term are showing as below:

FRA:NTP' s Net Margin % Range Over the Past 10 Years
Min: -1367460   Med: -75748.69   Max: -594.92
Current: -64751.1


FRA:NTP's Net Margin % is ranked worse than
97.14% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs FRA:NTP: -64751.10

Abliva AB Net Margin % Historical Data

The historical data trend for Abliva AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Net Margin % Chart

Abliva AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56,507.69 -28,076.19 -80,160.00 -258,533.33 -71,150.00

Abliva AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -18,800.00 - - -

Competitive Comparison of Abliva AB's Net Margin %

For the Biotechnology subindustry, Abliva AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abliva AB's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abliva AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Abliva AB's Net Margin % falls into.



Abliva AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Abliva AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-8.538/0.012
=-71,150.00 %

Abliva AB's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-1.721/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abliva AB  (FRA:NTP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Abliva AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Abliva AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abliva AB Business Description

Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase. . The company is focused on two projects. KL1333, a powerful NAD+ and NADH regulator, in late-stage development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement therapy, has just completed preclinical development.

Abliva AB Headlines

No Headlines